|
|
|
|
| Advertisement |
Personalized medicine: Commercializing drugs with companion diagnostics
Live Webinar: Thursday, December 1 at 11:00am EST
Register now
|
|
| Advertisement |
How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors
On Demand
 Learn more
|
|
|
| Global |
 |
|
Will Nice "Go Commercial"? |
The UK's NICE, like the NHS it supports, is looking at how to make big savings. One option is to get more "commercial". Leela Barham takes a look
… /Read more/ |
|
|
| Special Feature |
 |
|
Pharm Exec's 2017 Pipeline Report |
The industry is readying for a leap into a new age of complex therapies. Elaborate manufacturing and soaring drug costs, however, loom as deep chasms to cross in bridging the potential with reality
… /Read more/ |
|
|
|
ADVERTISEMENT
|
| Industry update |
| //Achaogen (South San Francisco, CA) announced the appointment of Gary Loeb as General Counsel.//Susan Vandegrift joined Evolve BioSystems (Davis, CA) as Chief Financial Officer.//Epizyme (Cambridge, MA) reported that its President of Research and Chief Scientific Officer, Robert A. Copeland, Ph.D., has been named a fellow of the American Association for the Advancement of Science (AAAS).// |
|
|
